Rhythm Pharmaceuticals (RYTM) Earnings Date, Estimates & Call Transcripts → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free RYTM Stock Alerts $39.14 +0.64 (+1.66%) (As of 05/10/2024 06:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 6EstimatedActual EPS (May. 7) -$2.35 Missed By -$0.01 Consensus EPS (May. 7) -$2.34 Read Call TranscriptListen to Call Get Rhythm Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for RYTM and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRYTM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RYTM Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Rhythm Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($4.43) EPSNext Year EPS Consensus Estimate: ($2.33) EPSRYTM Earnings Date and InformationRhythm Pharmaceuticals last issued its earnings results on May 7th, 2024. The reported ($2.35) EPS for the quarter, missing the consensus estimate of ($2.34) by $0.01. The firm earned $26 million during the quarter, compared to analysts' expectations of $26.90 million. Its quarterly revenue was up 126.1% compared to the same quarter last year. Rhythm Pharmaceuticals has generated ($4.63) earnings per share over the last year (($4.63) diluted earnings per share). Earnings for Rhythm Pharmaceuticals are expected to grow in the coming year, from ($4.43) to ($2.33) per share. Rhythm Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off prior year's report dates.Read More Rhythm Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/6/2024Estimated)------- 5/7/2024Q1 2024($2.34)($2.35)($0.01)($2.35)$26.90 million$26.00 million 2/22/2024Q4 2023($0.70)($0.70)-($0.70)$25.38 million$24.23 million 11/7/2023Q3 2023($0.76)($0.76)-($0.76)$22.18 million$22.50 million 8/1/2023Q2 2023($0.80)($0.82)($0.02)($0.82)$15.03 million$19.20 million 5/2/2023Q1 2023($0.71)($0.92)($0.21)($0.92)$12.12 million$11.50 million 3/1/2023Q4 2022($0.82)($0.75)+$0.07($0.75)$7.16 million$8.80 million Get the Latest News and Ratings for RYTM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rhythm Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/8/2022Q3 2022($1.01)($0.79)+$0.22($0.79)$5.36 million$4.28 million8/2/2022Q2 2022($0.79)($0.89)($0.10)($0.89)$21.65 million$9.07 million5/3/2022Q1 2022($0.98)($1.05)($0.07)($1.05)$2.45 million$1.50 million 3/1/2022Q4 2021($1.00)($0.85)+$0.15($0.85)$1.71 million$1.82 million 11/2/2021Q3 2021($0.83)($0.70)+$0.13($0.70)-$1.03 million 8/3/2021Q2 2021($0.75)($0.70)+$0.05($0.70)-$0.27 million Rhythm Pharmaceuticals Earnings - Frequently Asked Questions When is Rhythm Pharmaceuticals's earnings date? Rhythm Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on RYTM's earnings history. Did Rhythm Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Rhythm Pharmaceuticals (NASDAQ:RYTM) missed the analysts' consensus estimate of ($2.34) by $0.01 with a reported earnings per share (EPS) of ($2.35). Learn more on analysts' earnings estimate vs. RYTM's actual earnings. How can I listen to Rhythm Pharmaceuticals's earnings conference call? The conference call for Rhythm Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I read Rhythm Pharmaceuticals's conference call transcript? The conference call transcript for Rhythm Pharmaceuticals's latest earnings report can be read online. Read Transcript How much revenue does Rhythm Pharmaceuticals generate each year? Rhythm Pharmaceuticals (NASDAQ:RYTM) has a recorded annual revenue of $77.43 million. How much profit does Rhythm Pharmaceuticals generate each year? Rhythm Pharmaceuticals (NASDAQ:RYTM) has a recorded net income of -$184.68 million. RYTM has generated -$4.63 earnings per share over the last four quarters. What is Rhythm Pharmaceuticals's EPS forecast for next year? Rhythm Pharmaceuticals's earnings are expected to grow from ($4.43) per share to ($2.33) per share in the next year. More Earnings Resources from MarketBeat Related Companies: RNA Earnings Date PTCT Earnings Date INDV Earnings Date VERA Earnings Date ARVN Earnings Date GERN Earnings Date DYN Earnings Date MRVI Earnings Date CORT Earnings Date ARDX Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:RYTM) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersTrump is sounding the alarmPreserve GoldRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDoes this make you sick?Allegiance GoldThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorBill Clinton Backing Biden Replacement???The Freeport SocietyThis 1 Biotech Stock has been shocking the marketsHuge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rhythm Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.